Ischemic Stroke Clinical Trial
Official title:
Discharge Educational Strategies for Reduction of Vascular Events
DESERVE is a discharge education study using health workers to enroll and randomly assign 800 subjects diagnosed with TIA, or mild stroke to either risk factor education or usual care. Those patients assigned to education will receive stroke preparedness education plus risk factor reduction education, and help accessing follow up care with health workers. Those patients assigned to usual care will receive written stroke preparedness education. This protocol will evaluate the effectiveness of this intervention to reduce blood pressure, and individual stroke risk factors and future stroke risk.
Stroke and its risk factors disproportionately affect minority populations, and secondary
stroke prevention programs have had relatively little success. TIA and mild stroke patients
with few after-affects also stay in the hospital for a shorter period of time, and leave
without enough information about their risk for another stroke. Additionally, mild stroke and
TIA patients often do not follow-up with neurologists after they leave the hospital. DESERVE
is a discharge education study using health workers to enroll and randomly assign 800
subjects from MSSM, MSSM Queens and CUMC diagnosed with Transient Ischemic attack (TIA ),
mild Ischemic stroke (IS) or mild Intracerebral Hemorrhage (ICH) to either risk factor
education or usual care. Those patients assigned to education will receive education on
stroke preparedness education plus risk factor reduction education, and help accessing follow
up care with health workers. This education includes a power point presentation and a
patient-paced workbook and video on Risk perception, Medication Adherence, and
Patient-Physician Communication. To target the most appropriate mild IS/ICH and TIA survivors
for participation in this proposal, we will focus on survivors with mild stroke and TIA,
excluding those whose stroke deficits are severe enough to warrant discharge to a nursing
home or to require 24-hour care.
Those patients assigned to usual care will receive written stroke preparedness education.
This protocol will evaluate the effectiveness of this intervention to reduce blood pressure,
and individual stroke risk factors and future stroke risk. Additionally, we will evaluate the
ability of the these strategies to conduct education to affect positive change in taking
medications as directed, stroke knowledge 6 months and 12 months after hospital admission,
attendance at follow-up health care appointments, and cost-effectiveness. After 1 year
participants will be followed quarterly for up to 3 years to track events.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05196659 -
Collaborative Quality Improvement (C-QIP) Study
|
N/A | |
| Recruiting |
NCT06027788 -
CTSN Embolic Protection Trial
|
N/A | |
| Completed |
NCT03281590 -
Stroke and Cerebrovascular Diseases Registry
|
||
| Recruiting |
NCT05518305 -
Platelet Expression of FcγRIIa and Arterial Hemodynamics to Predict Recurrent Stroke in Intracranial Atherosclerosis
|
||
| Recruiting |
NCT06029959 -
Stroke and CPAP Outcome Study 3
|
N/A | |
| Recruiting |
NCT03728738 -
Zero Degree Head Positioning in Hyperacute Large Artery Ischemic Stroke
|
Phase 3 | |
| Terminated |
NCT03396419 -
IMPACT- 24col Collateral Blood Flow Assessment Following SPG Stimulation in Acute Ischemic Stroke (ImpACT-24B Sub-Study)
|
||
| Recruiting |
NCT05065216 -
Treatment of Acute Ischemic Stroke (ReMEDy2 Trial)
|
Phase 2/Phase 3 | |
| Recruiting |
NCT04897334 -
Transcranial Direct Current Stimulation and Rehabilitation to Ameliorate Impairments in Neurocognition After Stroke
|
N/A | |
| Not yet recruiting |
NCT06462599 -
Osteopontin Gene Polymorphism in Stroke Patients in Egypt
|
||
| Not yet recruiting |
NCT06032819 -
Differentiating Between Brain Hemorrhage and Contrast
|
||
| Not yet recruiting |
NCT06026696 -
Cohort of Neurovascular Diseases Treated in the Acute Phase and Followed at Lariboisière
|
||
| Recruiting |
NCT02910180 -
Genetic, Metabolic, and Growth Factor Repository for Cerebrovascular Disorders
|
||
| Withdrawn |
NCT01866189 -
Identification of Hypoxic Brain Tissues by F-MISO PET in Acute Ischemic Stroke
|
N/A | |
| Completed |
NCT02922452 -
A Study to Evaluate the Effect of Diltiazem on the Pharmacokinetics (PK) of BMS-986141 in Healthy Subjects
|
Phase 1 | |
| Completed |
NCT03554642 -
Walkbot Robotic Training for Improvement in Gait
|
Phase 3 | |
| Recruiting |
NCT03041753 -
Reperfusion Injury After Stroke Study
|
N/A | |
| Completed |
NCT02549846 -
AdminiStration of Statin On Acute Ischemic stRoke patienT Trial
|
Phase 4 | |
| Completed |
NCT01678534 -
Reparative Therapy in Acute Ischemic Stroke With Allogenic Mesenchymal Stem Cells From Adipose Tissue, Safety Assessment, a Randomised, Double Blind Placebo Controlled Single Center Pilot Clinical Trial
|
Phase 2 | |
| Completed |
NCT02610803 -
Paroxysmal Atrial Fibrillation in Patients With Acute Ischemic Stroke
|
N/A |